Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Where Now For Italy’s Drug Price Transparency Crusade?

All Eyes On New Head of Drugs Agency

Executive Summary

The signs suggest that Nicola Magrini, the new director general of the Italian medicines regulator, AIFA, will follow in the footsteps of his predecessor in fighting for transparency in drug pricing.

You may also be interested in...



UK Court Ruling Ends Novartis/Bayer Crusade Against Avastin In AMD

AMD patients in the UK can legitimately be given compounded bevacizumab (Roche’s Avastin) after the appeals court said NHS trusts could offer a drug off-label for economic reasons where there were no safety or efficacy concerns. 

Italian Regulator Promotes Availability Of Potential COVID-19 Treatments

Italy has so far borne the brunt of Europe’s growing coronavirus outbreak. Now it is offering patients the chance to access unauthorized medicines as part of efforts to stem the outbreak.

Strength In Numbers: The Rise Of Cross Country Collaboration In The EU

Countries across the EU have been joining forces over the past few years to discuss and collaborate on pharmaceutical policy issues. They are hoping among other things to secure more sustainable drug prices and get a better grasp on what new medicines are on the horizon.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM013214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel